Ligand Pharmaceuticals Inc (NASDAQ:LGND)

125.21
Delayed Data
As of 3:59pm ET
 -5.32 / -4.08%
Today’s Change
78.26
Today|||52-Week Range
219.75
+25.90%
Year-to-Date
Ligand (LGND) Q1 Earnings Top, Bad Weather Hits Captisol Sales
May 04 / Zacks.com - Paid Partner Content
Ligand Pharmaceuticals Inc (LGND) Q1 2021 Earnings Call Transcript
May 04 / MotleyFool.com - Paid Partner Content
Ligand's Revenue Soars in Q1 Thanks to Gilead's COVID Drug
May 04 / MotleyFool.com - Paid Partner Content
Ligand Pharmaceuticals (LGND) Tops Q1 Earnings Estimates
May 03 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close130.53
Today’s open122.74
Day’s range125.21 - 129.46
Volume8,273
Average volume (3 months)461,222
Market cap$2.2B
Data as of 3:59pm ET, 05/12/2021

Growth & Valuation

Earnings growth (last year)-100.56%
Earnings growth (this year)+35.19%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+54.98%
P/E ratio53.7
Price/Sales8.63
Price/Book2.99

Competitors

 Today’s
change
Today’s
% change
MDGLMadrigal Pharmaceuti...+0.59+0.44%
----
----
OPKOPKO Health Inc-0.09-2.78%
Data as of 4:00pm ET, 05/12/2021

Financials

Next reporting dateAugust 9, 2021
EPS forecast (this quarter)$1.34
Annual revenue (last year)$186.4M
Annual profit (last year)-$3.0M
Net profit margin-1.60%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts